{'fraction_non_alphanumeric': 0.042600896860986545, 'fraction_numerical': 0.0, 'mean_word_length': 5.478260869565218, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Mid‐regional pro‐atrial natriuretic peptide for the early detection of non‐acute heart failure

Diagnosing non‐acute heart failure (HF) remains challenging, notably in the early stages of the syndrome. The diagnostic value of mid‐regional pro‐atrial natriuretic peptide (MR‐proANP) has been proven in acute onset HF, but its role in early non‐acute HF is unknown. We aimed to determine the diagnostic value of MR‐proANP in suspected non‐acute HF.